MannKind Corp (NASDAQ:MNKD)

1.07
Delayed Data
As of Aug 17
 -0.06 / -5.31%
Today’s Change
0.98
Today|||52-Week Range
6.96
-53.88%
Year-to-Date

Today’s Trading

Previous close1.13
Today’s open1.12
Day’s range1.06 - 1.15
Volume1,091,732
Average volume (3 months)2,237,391
Market cap$169.8M
Data as of 4:00pm ET, 08/17/2018

Growth & Valuation

Earnings growth (last year)-183.09%
Earnings growth (this year)+32.74%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)-93.28%
P/E ratioNM
Price/Sales20.59
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.20-7.84%
BDSIBioDelivery Sciences...+0.05+1.79%
OMEDOncoMed Pharmaceutic...0.000.00%
CLSDClearside Biomedical...-0.20-2.87%
Data as of 6:30pm ET, 08/17/2018

Financials

Next reporting dateNovember 5, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$11.7M
Annual profit (last year)-$117.3M
Net profit margin-999.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial &
Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts